TrialJAMA dermatology2025

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.

Sonja Ständer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.